Pricing Log in Create free account

Panbela Therapeutics Inc. (PBLA) vs 60 Degrees Pharmaceuticals Inc. (SXTP)

Panbela Therapeutics Inc. and 60 Degrees Pharmaceuticals Inc. are both Biotechnology companies. Panbela Therapeutics Inc. and 60 Degrees Pharmaceuticals Inc. are of similar size ($3.4M and $3.2M). Panbela Therapeutics Inc. has the higher net margin (0.00% vs −650.3%) and the higher return on invested capital (0.00% vs −348.6%). Across the 12 metrics below, Panbela Therapeutics Inc. leads on 10 and 60 Degrees Pharmaceuticals Inc. on 2.

Valuation

Metric PBLA SXTP Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.88 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.04 9.21
Earnings yield 0.00% (252.37%) (33.15%)
Free cash flow yield 0.00% (397.08%) (25.50%)

Profitability

Metric PBLA SXTP Biotechnology median
Gross margin — 43.42% 65.16%
Operating margin 0.00% (691.33%) 0.00%
Net margin 0.00% (650.34%) 0.00%
Free cash flow margin 0.00% (745.93%) 0.00%
Return on equity 270.37% 110.82% (56.36%)
Return on assets (353.47%) (186.70%) (48.04%)
Return on invested capital 0.00% (348.64%) 0.00%

Growth

Metric PBLA SXTP Biotechnology median
Revenue growth (TTM) — 23.41% 6.02%
EPS growth (last fiscal year) 99.43% 84.19% 30.26%
Revenue growth, 5-year CAGR — (11.18%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PBLA SXTP Biotechnology median
Debt to equity (0.23) 0.00 0.00
Current ratio 0.26 2.32 4.72
Net debt to EBITDA (0.10) 0.37 0.96

Dividend

Metric PBLA SXTP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PBLA SXTP Biotechnology median
Market cap 3.35m 3.17m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack